Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/69585660-954c-8011-b9ec-bc5c70cfea17
(section)
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Assistant: Here are relevant studies and guideline references that support the ferritin thresholds and clinical practices used forβ¦ === Here are relevant studies and guideline references that support the ferritin thresholds and clinical practices used for Restless Legs Syndrome (RLS) and iron management: ===== π Clinical Guidelines & Consensus Statements ===== # American Academy of Sleep Medicine (AASM) RLS & PLMD Clinical Practice Guideline (2025) - Recommends iron supplementation (oral or IV) if serum ferritin β€ 75 ng/mL or transferrin saturation < 20%. - Suggests IV iron if ferritin 75β100 ng/mL. - These are consensus-based recommendations used clinically. PubMed<ref>{{cite web|title=PubMed|url=https://pubmed.ncbi.nlm.nih.gov/39324694/|publisher=pubmed.ncbi.nlm.nih.gov|access-date=2026-01-03}}</ref> # AASM Iron Target Overview & Thresholds - Iron studies are recommended for all significant RLS cases. - Ferritin intervention cutoff of 75 ng/mL is emphasized, differing from general iron deficiency cutoffs. e-jsm.org<ref>{{cite web|title=e-jsm.org|url=https://www.e-jsm.org/journal/view.php?number=406|publisher=e-jsm.org|access-date=2026-01-03}}</ref> # Consensus review on iron and RLS (Allen et al., 2018) - Oral iron may be effective for treating RLS in individuals with serum ferritin β€ 75 Β΅g/L. - IV iron therapies reviewed for severe or refractory cases. ScienceDirect<ref>{{cite web|title=ScienceDirect|url=https://www.sciencedirect.com/science/article/pii/S1389945717315599|publisher=sciencedirect.com|access-date=2026-01-03}}</ref> ===== π¬ Supportive Research Findings ===== # Schulte et al. (2014): Iron in RLS treatment overview - Reports that low-normal ferritin (< 50 ng/mL) is often associated with more severe RLS and that oral iron benefits those with lower ferritin readings. - This paper cites several smaller studies showing response to iron therapy in RLS with low ferritin. PMC<ref>{{cite web|title=PMC|url=https://pmc.ncbi.nlm.nih.gov/articles/PMC6183309/|publisher=pmc.ncbi.nlm.nih.gov|access-date=2026-01-03}}</ref> # Wang et al. (2009) β RCT on oral iron for RLS - This randomized, placebo-controlled trial found that oral iron improved RLS symptoms in patients with low-normal ferritin levels compared with placebo, supporting targeting higher ferritin in treatment contexts. PubMed<ref>{{cite web|title=PubMed|url=https://pubmed.ncbi.nlm.nih.gov/19230757/|publisher=pubmed.ncbi.nlm.nih.gov|access-date=2026-01-03}}</ref> # Li et al. (2023) meta-analysis on low serum ferritin and RLS augmentation - Lower serum ferritin is shown to be associated with RLS augmentation (worsening symptoms due to treatment), supporting the idea that iron status relates to RLS severity. ScienceDirect<ref>{{cite web|title=ScienceDirect|url=https://www.sciencedirect.com/science/article/abs/pii/S1389945723004008|publisher=sciencedirect.com|access-date=2026-01-03}}</ref> ===== π Clinical Threshold Summaries (from guideline literature) ===== * Ferritin β€ 75 ng/mL: Primary trigger for iron supplementation consideration in adults with RLS β common threshold used in guidelines and consensus. PubMed<ref>{{cite web|title=PubMed|url=https://pubmed.ncbi.nlm.nih.gov/39324694/|publisher=pubmed.ncbi.nlm.nih.gov|access-date=2026-01-03}}</ref> * Ferritin β€ 50 ng/mL: Frequently cited intervention cutoff in older data and some clinical contexts. Harvard Health<ref>{{cite web|title=Harvard Health|url=https://www.health.harvard.edu/diseases-and-conditions/are-you-missing-this-simple-treatment-for-restless-legs|publisher=Harvard Health|access-date=2026-01-03}}</ref> * Ferritin 75β100 ng/mL: Often considered for IV iron if oral therapy is insufficient or poorly absorbed. PubMed<ref>{{cite web|title=PubMed|url=https://pubmed.ncbi.nlm.nih.gov/39324694/|publisher=pubmed.ncbi.nlm.nih.gov|access-date=2026-01-03}}</ref> ===== π Key Takeaway ===== The ferritin levels associated with RLS triggers and treatment targets are not based on a single definitive cutoff from one large trial, but rather: * Clinical guidelines and consensus group around β€ 75 ng/mL ferritin as the level at which iron supplementation should be considered in adults with RLS. PubMed<ref>{{cite web|title=PubMed|url=https://pubmed.ncbi.nlm.nih.gov/39324694/|publisher=pubmed.ncbi.nlm.nih.gov|access-date=2026-01-03}}</ref> * Older supportive data point to lower thresholds (around β€ 50 ng/mL) also being meaningful. Harvard Health<ref>{{cite web|title=Harvard Health|url=https://www.health.harvard.edu/diseases-and-conditions/are-you-missing-this-simple-treatment-for-restless-legs|publisher=Harvard Health|access-date=2026-01-03}}</ref> * There is evidence of improved RLS symptoms with iron therapy in patients with low to low-normal ferritin in RCTs and observational studies. PubMed<ref>{{cite web|title=PubMed|url=https://pubmed.ncbi.nlm.nih.gov/19230757/|publisher=pubmed.ncbi.nlm.nih.gov|access-date=2026-01-03}}</ref> If you want, I can pull specific PDF links to the full text of some of these guideline documents or studies for deeper review.
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)